Jiangping Fu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jiangping Fu has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Guirong Wu
Dazhou Central Hospital
2 shared publications- Jie Li
Department of Clinical Research Center, Dazhou Central Hospital, Dazhou, China
2 shared publications Qian Yang
Dazhou Central Hospital
2 shared publicationsYao Rao
Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Southwest Medical University
2 shared publicationsYoushu Gao
Dazhou Central Hospital
2 shared publicationsFang Hu
Dazhou Central Hospital
1 shared publication
Latest Publications
- Open Access
- 13 October 2026
- Published by Frontiers Media SA in Frontiers in Global Women's Health
- Vol. 7, 1695260
Trachea, bronchus, and lung cancer in women of reproductive age: global burden trends from 1990 to 2021 and forecasts to 2035
Background: In recent decades, cancers of the trachea, bronchus and lung cancer (TBL) have been the cancers with the highest global morbidity and mortality rates, with large regional variations, and the highest economic burden of all cancer types, and have shown a clear trend towards feminisation and younger onset. Therefore, we aimed to provide comprehensive insights into the prevalence and impact of TBL in women of reproductive age, taking into account factors such as age and socio-demographic indices (SDI). Methods: To assess trends in the prevalence of TBL among women of reproductive age, we used the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 to systematically assess the burden of CBD and its changes globally, regionally, and nationally from 1990 to 2021. We calculated estimated annual percentage change (EAPC), age-standardised incidence rates (ASIR), age-standardised death rates (ASDR) and disability-adjusted life years (DALYs) for 204 countries and regions from 1990 to 2021. DALYs were used as a measure in conjunction with socio-demographic indices (SDIs). Analyses include the Inequality Slope Index (ISI) and the Concentration Index (CI) to measure health inequalities, frontier analyses to estimate achievable outcomes based on levels of development, decomposition analyses to identify drivers of change in the burden of disease, analysis of yearly cyclical cohort models, and Bayesian age-period-cohort (BAPC) modelling to predict future trends in the burden of disease. Results: Compared with 1990, there was an increase in global morbidity and mortality from TBL in women of childbearing age in 2021, but there was a decrease in global morbidity and mortality, with the most pronounced downward trend in TBL in women of childbearing age in the 45–49 age group. In contrast, the global rate of DALYs increased, and the highest rate of DALYs in women of reproductive age was found in the 45–49 age group. Only low-SDI regions and medium-low-SDI regions had increased incidence and mortality rates of the 21 GBD regions, East Asia had the highest incidence and mortality rates of the 204 countries, Nigeria had the lowest incidence and mortality rates, Greenland had the highest incidence rates, and Monaco had the highest mortality rates in 2021. From 1990 to 2021, absolute and relative inequality associated with the socio-demographic index (SDI) decreases, but inequality persists. Projections of ASR for women of childbearing age from 2021 to 2035 found an overall declining trend in TBL ASIR and ASMR for women of childbearing age from 2021 onwards. Conclusion: Although the global age-standardised DALY rates for ASIR, ASDR and TBL in women of reproductive age have decreased over the past three decades, the global burden of TBL is unevenly distributed. Moreover, the prevention and control of TBL in women of reproductive age require international cooperation, multisectoral collaboration, government support, and the joint efforts of women themselves and their families and societies.
- 13 October 2026
- Published by Frontiers Media SA in Frontiers in Global Women's Health
- Vol. 7, 1695260
Open AccessTrachea, bronchus, and lung cancer in women of reproductive age: global burden trends from 1990 to 2021 and forecasts to 2035
Background: In recent decades, cancers of the trachea, bronchus and lung cancer (TBL) have been the cancers with the highest global morbidity and mortality rates, with large regional variations, and the highest economic burden of all cancer types, and have shown a clear trend towards feminisation and younger onset. Therefore, we aimed to provide comprehensive insights into the prevalence and impact of TBL in women of reproductive age, taking into account factors such as age and socio-demographic indices (SDI). Methods: To assess trends in the prevalence of TBL among women of reproductive age, we used the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 to systematically assess the burden of CBD and its changes globally, regionally, and nationally from 1990 to 2021. We calculated estimated annual percentage change (EAPC), age-standardised incidence rates (ASIR), age-standardised death rates (ASDR) and disability-adjusted life years (DALYs) for 204 countries and regions from 1990 to 2021. DALYs were used as a measure in conjunction with socio-demographic indices (SDIs). Analyses include the Inequality Slope Index (ISI) and the Concentration Index (CI) to measure health inequalities, frontier analyses to estimate achievable outcomes based on levels of development, decomposition analyses to identify drivers of change in the burden of disease, analysis of yearly cyclical cohort models, and Bayesian age-period-cohort (BAPC) modelling to predict future trends in the burden of disease. Results: Compared with 1990, there was an increase in global morbidity and mortality from TBL in women of childbearing age in 2021, but there was a decrease in global morbidity and mortality, with the most pronounced downward trend in TBL in women of childbearing age in the 45–49 age group. In contrast, the global rate of DALYs increased, and the highest rate of DALYs in women of reproductive age was found in the 45–49 age group. Only low-SDI regions and medium-low-SDI regions had increased incidence and mortality rates of the 21 GBD regions, East Asia had the highest incidence and mortality rates of the 204 countries, Nigeria had the lowest incidence and mortality rates, Greenland had the highest incidence rates, and Monaco had the highest mortality rates in 2021. From 1990 to 2021, absolute and relative inequality associated with the socio-demographic index (SDI) decreases, but inequality persists. Projections of ASR for women of childbearing age from 2021 to 2035 found an overall declining trend in TBL ASIR and ASMR for women of childbearing age from 2021 onwards. Conclusion: Although the global age-standardised DALY rates for ASIR, ASDR and TBL in women of reproductive age have decreased over the past three decades, the global burden of TBL is unevenly distributed. Moreover, the prevention and control of TBL in women of reproductive age require international cooperation, multisectoral collaboration, government support, and the joint efforts of women themselves and their families and societies.
- Open Access
- 1 April 2025
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 14 (4) , 2457-2469
Role of TRKC and NT-3 proteins in the progression and prognosis of colorectal cancer
Background: Colorectal cancer (CRC) is a common tumor of the digestive system. In recent years, CRC has had the fourth highest incidence and second highest mortality rate among tumors worldwide. Therefore, it is important to identify new molecular markers, and examine their relationship with the clinicopathological features and prognosis of CRC patients. This study examined the correlation between the expression levels of the tropomyosin receptor kinase C (TRKC) and neurotrophic factor-3 (NT-3) proteins, and the clinicopathological features and prognosis of CRC patients. Methods: In total, 141 paraffin-embedded specimens from patients who had undergone radical surgical resection for CRC were analyzed. All CRC diagnoses were confirmed by pathological examination. Corresponding adjacent normal tissues served as controls. Immunohistochemical staining was employed to assess the expression of the TRKC and NT-3 proteins in both the CRC and adjacent normal tissues. A subsequent statistical analysis was conducted to explore the associations between the expression levels of these proteins, and the clinicopathological features and prognostic outcomes of CRC patients. Results: The expression level of TRKC was significantly higher in the CRC tissues than the adjacent normal tissues, while the expression level of NT-3 was significantly lower in the CRC tissues than the adjacent normal tissues, and the observed differences were statistically significant (PTRKC expression was significantly correlated with the tumor site (PTRKC had significantly shorter overall survival (OS) and progression-free survival (PFS) times than those with negative TRKC expression (PNT-3 expression was significantly associated with lymph node metastasis (PNT-3 expression had prolonged OS and PFS compared to those with negative NT-3 expression (PTRKC expression had a hazard ratio (HR) of 2.679 (PNT-3 expression had a HR of 0.433 (PConclusions: We found that the TRKC and NT-3 proteins were closely associated with the occurrence, metastasis, invasion, and tumor marker levels of CRC, and can be used as independent predictors of prognosis in patients with CRC. TRKC mainly indicates a poor prognosis in CRC, while NT-3 indicates a good prognosis.
- 1 April 2025
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 14 (4) , 2457-2469
Open AccessRole of TRKC and NT-3 proteins in the progression and prognosis of colorectal cancer
Background: Colorectal cancer (CRC) is a common tumor of the digestive system. In recent years, CRC has had the fourth highest incidence and second highest mortality rate among tumors worldwide. Therefore, it is important to identify new molecular markers, and examine their relationship with the clinicopathological features and prognosis of CRC patients. This study examined the correlation between the expression levels of the tropomyosin receptor kinase C (TRKC) and neurotrophic factor-3 (NT-3) proteins, and the clinicopathological features and prognosis of CRC patients. Methods: In total, 141 paraffin-embedded specimens from patients who had undergone radical surgical resection for CRC were analyzed. All CRC diagnoses were confirmed by pathological examination. Corresponding adjacent normal tissues served as controls. Immunohistochemical staining was employed to assess the expression of the TRKC and NT-3 proteins in both the CRC and adjacent normal tissues. A subsequent statistical analysis was conducted to explore the associations between the expression levels of these proteins, and the clinicopathological features and prognostic outcomes of CRC patients. Results: The expression level of TRKC was significantly higher in the CRC tissues than the adjacent normal tissues, while the expression level of NT-3 was significantly lower in the CRC tissues than the adjacent normal tissues, and the observed differences were statistically significant (PTRKC expression was significantly correlated with the tumor site (PTRKC had significantly shorter overall survival (OS) and progression-free survival (PFS) times than those with negative TRKC expression (PNT-3 expression was significantly associated with lymph node metastasis (PNT-3 expression had prolonged OS and PFS compared to those with negative NT-3 expression (PTRKC expression had a hazard ratio (HR) of 2.679 (PNT-3 expression had a HR of 0.433 (PConclusions: We found that the TRKC and NT-3 proteins were closely associated with the occurrence, metastasis, invasion, and tumor marker levels of CRC, and can be used as independent predictors of prognosis in patients with CRC. TRKC mainly indicates a poor prognosis in CRC, while NT-3 indicates a good prognosis.
- Open Access
- 30 August 2024
- Published by Springer Nature in Discover Oncology
- Vol. 15 (1) , 1-20
Construction and analysis of a lysosome-dependent cell death score-based prediction model for non-small cell lung cancer
Background Non-small cell lung cancer (NSCLC) is the most common type of tumor globally and the leading cause of cancer-related deaths. Although treatment strategies such as immune checkpoint inhibitors and chemotherapy have advanced, the heterogeneity among NSCLC patients results in significant variability in treatment outcomes. Studies have shown that certain patients respond poorly to immune checkpoint inhibitors, indicating that treatment response is closely related to multiple factors. Therefore, it is necessary to develop predictive models to stratify patients based on gene expression and clinical characteristics, aiming for precision therapy. Objective This study aims to construct a stratified prognostic model for NSCLC patients based on lysosome-dependent cell death (LDCD) scoring by integrating single-cell RNA sequencing (scRNA-seq) and bulk RNA sequencing data. By analyzing the immune-related characteristics of high-risk and low-risk groups, we further explored the impact of cell death patterns on lung cancer and identified potential therapeutic targets. Methods This study obtained single-cell RNA sequencing data and gene expression data of NSCLC patients and normal lung tissues from the GEO and TCGA databases. We used R packages such as Seurat and CellChat for data preprocessing and analysis, and performed dimensionality reduction and visualization through Principal Component Analysis (PCA) and UMAP algorithms. LASSO regression analysis was used to construct the predictive model, followed by cross-validation and ROC curve analysis. The model’s effectiveness was validated through survival analysis and immune microenvironment analysis. Results The study showed a significant increase in the proportion of monocytes in NSCLC tissues, suggesting their important role in cancer progression. Cell communication analysis indicated that macrophages, smooth muscle cells, and myeloid cells exhibit strong intercellular communication during cancer progression. Using the constructed prognostic model based on 12 LDCD-related genes, we found significant differences in overall survival and immune microenvironment between the high-risk and low-risk groups.
- 30 August 2024
- Published by Springer Nature in Discover Oncology
- Vol. 15 (1) , 1-20
Open AccessConstruction and analysis of a lysosome-dependent cell death score-based prediction model for non-small cell lung cancer
Background Non-small cell lung cancer (NSCLC) is the most common type of tumor globally and the leading cause of cancer-related deaths. Although treatment strategies such as immune checkpoint inhibitors and chemotherapy have advanced, the heterogeneity among NSCLC patients results in significant variability in treatment outcomes. Studies have shown that certain patients respond poorly to immune checkpoint inhibitors, indicating that treatment response is closely related to multiple factors. Therefore, it is necessary to develop predictive models to stratify patients based on gene expression and clinical characteristics, aiming for precision therapy. Objective This study aims to construct a stratified prognostic model for NSCLC patients based on lysosome-dependent cell death (LDCD) scoring by integrating single-cell RNA sequencing (scRNA-seq) and bulk RNA sequencing data. By analyzing the immune-related characteristics of high-risk and low-risk groups, we further explored the impact of cell death patterns on lung cancer and identified potential therapeutic targets. Methods This study obtained single-cell RNA sequencing data and gene expression data of NSCLC patients and normal lung tissues from the GEO and TCGA databases. We used R packages such as Seurat and CellChat for data preprocessing and analysis, and performed dimensionality reduction and visualization through Principal Component Analysis (PCA) and UMAP algorithms. LASSO regression analysis was used to construct the predictive model, followed by cross-validation and ROC curve analysis. The model’s effectiveness was validated through survival analysis and immune microenvironment analysis. Results The study showed a significant increase in the proportion of monocytes in NSCLC tissues, suggesting their important role in cancer progression. Cell communication analysis indicated that macrophages, smooth muscle cells, and myeloid cells exhibit strong intercellular communication during cancer progression. Using the constructed prognostic model based on 12 LDCD-related genes, we found significant differences in overall survival and immune microenvironment between the high-risk and low-risk groups.